Think Outside the Street
Results 1 - 10 of 1450 : 1 2 3 4 5 6 7 8 9 Next
Modified Study, Same Bloody Results
Merck's vorapaxar still causing bleeding.
These stocks just rolled over. Can they come back?
Keep your eye on margins.
This Just In: Upgrades and Downgrades
Bank of America relents on Dendreon.
New CEO = Dendreon Takeover Target?
After Provenge launch, Dendreon looks for new leadership at Savient.
Pfizer loses Lipitor exclusivity and still beats analysts.
Highest-Yielding Stocks Unlikely to Blow Up
Searching for safe in all the right places.
Eli Lilly Beats on EPS but GAAP Results Lag
Just the facts, Fool.
Third time's the charm for Amylin's Bydureon.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK